• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
How Do People Who Undergo Ketamine Treatment for a Psychiatric Problem Subjectively Experience This Intervention? A Meta-Synthesis of Qualitative Studies.接受氯胺酮治疗精神疾病的人对这种干预措施的主观体验如何?一项定性研究的元综合分析。
Int J Ment Health Nurs. 2025 Feb;34(1):e13425. doi: 10.1111/inm.13425. Epub 2024 Sep 16.
2
Subjective experience and meaning of delusions in psychosis: a systematic review and qualitative evidence synthesis.精神病中妄想的主观体验与意义:一项系统综述和定性证据综合分析
Lancet Psychiatry. 2022 Jun;9(6):458-476. doi: 10.1016/S2215-0366(22)00104-3. Epub 2022 May 4.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Health professionals' experience of teamwork education in acute hospital settings: a systematic review of qualitative literature.医疗专业人员在急症医院环境中团队合作教育的经验:对定性文献的系统综述
JBI Database System Rev Implement Rep. 2016 Apr;14(4):96-137. doi: 10.11124/JBISRIR-2016-1843.
5
Impact of summer programmes on the outcomes of disadvantaged or 'at risk' young people: A systematic review.暑期项目对处境不利或“有风险”的年轻人的影响:一项系统综述。
Campbell Syst Rev. 2024 Jun 13;20(2):e1406. doi: 10.1002/cl2.1406. eCollection 2024 Jun.
6
Care giving and receiving for people with complex emotional needs within a crisis resolution/home treatment setting: A qualitative evidence synthesis.危机解决/家庭治疗环境中具有复杂情感需求人群的照护提供和接受:定性证据综合
J Psychiatr Ment Health Nurs. 2024 Oct;31(5):788-802. doi: 10.1111/jpm.13033. Epub 2024 Feb 12.
7
Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies.精神障碍的迷幻治疗:定性研究中患者体验的系统评价和主题综合。
CNS Drugs. 2020 Sep;34(9):925-946. doi: 10.1007/s40263-020-00748-y.
8
Ketamine as a mental health treatment: Are acute psychoactive effects associated with outcomes? A systematic review.氯胺酮治疗精神健康:急性精神活性作用与结果有关吗?系统综述。
Behav Brain Res. 2020 Aug 17;392:112629. doi: 10.1016/j.bbr.2020.112629. Epub 2020 May 30.
9
The experience of loneliness among young people with depression: a qualitative meta-synthesis of the literature.年轻人抑郁症孤独感体验的研究:文献的定性元分析。
BMC Psychiatry. 2020 Aug 24;20(1):415. doi: 10.1186/s12888-020-02818-3.
10
Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS.给编辑的信:《ICD-11 与 DSM-5 心境障碍分类的趋同与分歧》
Turk Psikiyatri Derg. 2021;32(4):293-295. doi: 10.5080/u26899.

本文引用的文献

1
Ketamine for the treatment of major depression: a systematic review and meta-analysis.氯胺酮治疗重度抑郁症:一项系统评价与荟萃分析。
EClinicalMedicine. 2023 Aug 3;62:102127. doi: 10.1016/j.eclinm.2023.102127. eCollection 2023 Aug.
2
Imprinting: expanding the extra-pharmacological model of psychedelic drug action to incorporate delayed influences of sets and settings.印记:扩展迷幻药物作用的非药理学模型,以纳入心境和环境的延迟影响。
Front Hum Neurosci. 2023 Jul 18;17:1200393. doi: 10.3389/fnhum.2023.1200393. eCollection 2023.
3
Ketamine in neuropsychiatric disorders: an update.氯胺酮在神经精神疾病中的应用:最新进展。
Neuropsychopharmacology. 2024 Jan;49(1):23-40. doi: 10.1038/s41386-023-01632-1. Epub 2023 Jun 20.
4
Repeated oral esketamine in patients with treatment resistant depression and comorbid posttraumatic stress disorder.难治性抑郁症合并创伤后应激障碍患者重复口服艾司氯胺酮治疗
Heliyon. 2023 May 4;9(5):e15883. doi: 10.1016/j.heliyon.2023.e15883. eCollection 2023 May.
5
Phenomenology and therapeutic potential of patient experiences during oral esketamine treatment for treatment-resistant depression: an interpretative phenomenological study.口服依他佐辛治疗难治性抑郁症患者体验的现象学和治疗潜力:诠释现象学研究。
Psychopharmacology (Berl). 2023 Jul;240(7):1547-1560. doi: 10.1007/s00213-023-06388-6. Epub 2023 May 24.
6
Rapid neuroplasticity changes and response to intravenous ketamine: a randomized controlled trial in treatment-resistant depression.快速神经可塑性变化与静脉注射氯胺酮的反应:治疗抵抗性抑郁症的随机对照试验。
Transl Psychiatry. 2023 May 9;13(1):159. doi: 10.1038/s41398-023-02451-0.
7
Ketamine and psychotherapy for the treatment of psychiatric disorders: systematic review.氯胺酮与心理治疗用于精神障碍的治疗:系统评价
BJPsych Open. 2023 May 2;9(3):e79. doi: 10.1192/bjo.2023.53.
8
Ketamine-assisted psychotherapy in adolescents with multiple psychiatric diagnoses.氯胺酮辅助心理治疗用于患有多种精神疾病诊断的青少年。
Front Psychiatry. 2023 Mar 30;14:1141988. doi: 10.3389/fpsyt.2023.1141988. eCollection 2023.
9
It is not and never has been just about the drug: The need to emphasise psychotherapy in psychedelic-assisted psychotherapy.这不仅仅关乎药物,而且从来都不仅仅关乎药物:在迷幻剂辅助心理治疗中强调心理治疗的必要性。
Int J Ment Health Nurs. 2023 Jun;32(3):945-946. doi: 10.1111/inm.13147. Epub 2023 Mar 30.
10
Ketamine-Assisted Group Psychotherapy for Frontline Healthcare Workers with COVID-19-Related Burnout and PTSD: A Case Series of Effectiveness/Safety for 10 Participants.氯胺酮辅助团体心理治疗用于 COVID-19 相关倦怠和 PTSD 的一线医护人员:10 名参与者的有效性/安全性病例系列。
J Psychoactive Drugs. 2024 Jan-Mar;56(1):23-32. doi: 10.1080/02791072.2023.2186285. Epub 2023 Mar 2.

接受氯胺酮治疗精神疾病的人对这种干预措施的主观体验如何?一项定性研究的元综合分析。

How Do People Who Undergo Ketamine Treatment for a Psychiatric Problem Subjectively Experience This Intervention? A Meta-Synthesis of Qualitative Studies.

作者信息

Trimmel Melanie, Renner Antonia, Kaltenboeck Alexander

机构信息

Clinical Division of Social Psychiatry, Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.

出版信息

Int J Ment Health Nurs. 2025 Feb;34(1):e13425. doi: 10.1111/inm.13425. Epub 2024 Sep 16.

DOI:10.1111/inm.13425
PMID:39283006
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11751762/
Abstract

Ketamine treatment has shown promising effects for different mental disorders. Yet, little is known on how people who receive ketamine for a psychiatric problem subjectively experience undergoing this intervention. We conducted a systematic literature search to identify relevant qualitative research on the first-person experience of undergoing ketamine treatment in a psychiatric context. 24 eligible studies were identified and analysed using a thematic meta-synthesis approach. Three main themes were identified. First, 'The Ketamine treatment experience can be understood as a three-stage journey with unique clinical features at each stage'. Second, 'The subjective experience of acute ketamine treatment is multifaceted and complex'. Third, 'Ketamine treatment can have different positive effects-but what happens if it does not work?'. In summary, the subjective experience of receiving ketamine treatment for a psychiatric problem can be understood as a journey whereby patients move towards, then undergo, and eventually depart from ketamine. Before treatment, the experiential focus lies on expectations, hopes, and feelings towards the drug. During treatment, the drug's multifaceted psychotropic effects and how they are emotionally appraised become central to experience. Once treatment is finished, the focus is on the presence or absence of clinically relevant effects. The conceptual framework we propose can guide further qualitative research on this topic and aid mental health professionals to better understand the experience of patients who undergo ketamine treatment for a psychiatric problem.

摘要

氯胺酮治疗已显示出对不同精神障碍有显著疗效。然而,对于因精神问题接受氯胺酮治疗的人如何主观体验这种干预措施,我们却知之甚少。我们进行了一项系统的文献检索,以确定有关在精神科背景下接受氯胺酮治疗的第一人称体验的相关定性研究。通过主题元综合方法确定并分析了24项符合条件的研究。确定了三个主要主题。第一,“氯胺酮治疗体验可被理解为一个三阶段的过程,每个阶段都有独特的临床特征”。第二,“急性氯胺酮治疗的主观体验是多方面且复杂的”。第三,“氯胺酮治疗可能有不同的积极效果——但如果不起作用会怎样?”。总之,因精神问题接受氯胺酮治疗的主观体验可被理解为一个过程,在此过程中患者走向、经历并最终离开氯胺酮治疗。治疗前,体验的重点在于对药物的期望、希望和感受。治疗期间,药物多方面的精神otropic作用以及对其的情感评估成为体验的核心。一旦治疗结束,重点在于是否存在临床相关效果。我们提出的概念框架可以指导关于该主题的进一步定性研究,并帮助心理健康专业人员更好地理解因精神问题接受氯胺酮治疗的患者的体验。